Literature DB >> 7374352

A short lipopeptide, representative of a new family of immunological adjuvants devoid of sugar.

D Migliore-Samour, J Bouchaudon, F Floc'h, A Zerial, L Ninet, G H Werner, P Jollès.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7374352     DOI： 10.1016/0024-3205(80)90351-3

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  6 in total

Review 1.  Immunomodulating peptides.

Authors:  G H Werner; F Floc'h; D Migliore-Samour; P Jollès
Journal:  Experientia       Date:  1986-05-15

2.  Immunostimulating lipopeptide, LtriP (RP 56142): comparison of the effect on hepatic cytochrome P 450 modulation and radioprotection in male and female of three mouse strains.

Authors:  M Sedqi; M Delaforge; D Mansuy; B Martin; P Jollès; D Migliore-Samour
Journal:  Experientia       Date:  1995-08-16

3.  Apyrogenic synthetic desmuramyldipeptide, LK-409, with immunomodulatory properties.

Authors:  M Sollner; V Kotnik; S Pecar; A Stace; S Simcic; L Povsic; B Herzog-Wraber; L Klampfer; A Ihan; P Grosman
Journal:  Agents Actions       Date:  1993-03

4.  In vivo effects of immunostimulating lipopeptides on mouse liver microsomal cytochromes P-450 and on paracetamol-induced toxicity.

Authors:  D Migliore-Samour; M Delaforge; M Jaouen; D Mansuy; P Jollès
Journal:  Experientia       Date:  1989-09-15

5.  Radioprotective effects of the immunostimulating lauroylpeptide LtriP (RP 56142).

Authors:  D Migliore-Samour; A Bousseau; J M Caillaud; A Naussac; M Sedqi; C Ferradini; P Jollès
Journal:  Experientia       Date:  1993-02-15

Review 6.  Harnessing the untapped potential of nucleotide-binding oligomerization domain ligands for cancer immunotherapy.

Authors:  Sanja Nabergoj; Irena Mlinarič-Raščan; Žiga Jakopin
Journal:  Med Res Rev       Date:  2018-12-13       Impact factor: 12.944
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.